Search research articles
Contact Us
Filters
Showing results (261-270 of 283) with videos related to
Page
of 29
Sort By:
Leukemia
|
June 15, 2026
Allogeneic hematopoietic cell transplantation for T-cell/histiocyte-rich large B-cell lymphoma: An EBMT lymphoma working party study
Simon Renders, Maud Ngoya, Laurence de Leval, et al.
Clinical Lymphoma, Myeloma & Leukemia
|
July 12, 2017
Baseline Characteristics Predicting Very Good Outcome of Allogeneic Hematopoietic Cell Transplantation in Young Patients With High Cytogenetic Risk Chronic Lymphocytic Leukemia - A Retrospective Analysis From the Chronic Malignancies Working Party of the EBMT
Michel van Gelder, Dimitris Ziagkos, Liesbeth de Wreede, et al.
Bone Marrow Transplantation
|
May 13, 2024
Correction: Treosulfan compared to busulfan in allogeneic haematopoietic stem cell transplantation for myelofibrosis: a registry-based study from the Chronic Malignancies Working Party of the EBMT
Marie Robin, Simona Iacobelli, Linda Koster, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation
|
April 9, 2017
Impact of Molecular Genetics on Outcome in Myelofibrosis Patients after Allogeneic Stem Cell Transplantation
Nicolaus Kröger, Victoria Panagiota, Anita Badbaran, et al.
Bone Marrow Transplantation
|
March 20, 2024
Allogeneic hematopoietic stem-cell transplantation for patients with Richter transformation: a retrospective study on behalf of the Chronic Malignancies Working Party of the EBMT
Romain Guièze, Diderik-Jan Eikema, Linda Koster, et al.
Bone Marrow Transplantation
|
March 16, 2024
Treosulfan compared to busulfan in allogeneic haematopoietic stem cell transplantation for myelofibrosis: a registry-based study from the Chronic Malignancies Working Party of the EBMT
Marie Robin, Simona Iacobelli, Linda Koster, et al.
Bone Marrow Transplantation
|
January 10, 2024
Allogeneic haematopoietic cell transplantation for therapy-related myeloid neoplasms arising following treatment for lymphoma: a retrospective study on behalf of the Chronic Malignancies Working Party of the EBMT
Mitja Nabergoj, Diderik-Jan Eikema, Linda Koster, et al.
Blood
|
September 8, 2018
Measurable residual disease monitoring by NGS before allogeneic hematopoietic cell transplantation in AML
Felicitas Thol, Razif Gabdoulline, Alessandro Liebich, et al.
Neuron
|
June 1, 2022
Ketamine exerts its sustained antidepressant effects via cell-type-specific regulation of Kcnq2
Juan Pablo Lopez, Malte D Lücken, Elena Brivio, et al.
Blood Advances
|
May 4, 2023
The utility of biomarkers in acute GVHD prognostication
Nikolaos Spyrou, Yu Akahoshi, Francis Ayuk, et al.
Page
of 29
Search research articles
Search
Showing results (261-270 of 283) with videos related to
Sort By:
Page
of 29
Leukemia
|
June 15, 2026
Allogeneic hematopoietic cell transplantation for T-cell/histiocyte-rich large B-cell lymphoma: An EBMT lymphoma working party study
Simon Renders, Maud Ngoya, Laurence de Leval, et al.
Clinical Lymphoma, Myeloma & Leukemia
|
July 12, 2017
Baseline Characteristics Predicting Very Good Outcome of Allogeneic Hematopoietic Cell Transplantation in Young Patients With High Cytogenetic Risk Chronic Lymphocytic Leukemia - A Retrospective Analysis From the Chronic Malignancies Working Party of the EBMT
Michel van Gelder, Dimitris Ziagkos, Liesbeth de Wreede, et al.
Bone Marrow Transplantation
|
May 13, 2024
Correction: Treosulfan compared to busulfan in allogeneic haematopoietic stem cell transplantation for myelofibrosis: a registry-based study from the Chronic Malignancies Working Party of the EBMT
Marie Robin, Simona Iacobelli, Linda Koster, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation
|
April 9, 2017
Impact of Molecular Genetics on Outcome in Myelofibrosis Patients after Allogeneic Stem Cell Transplantation
Nicolaus Kröger, Victoria Panagiota, Anita Badbaran, et al.
Bone Marrow Transplantation
|
March 20, 2024
Allogeneic hematopoietic stem-cell transplantation for patients with Richter transformation: a retrospective study on behalf of the Chronic Malignancies Working Party of the EBMT
Romain Guièze, Diderik-Jan Eikema, Linda Koster, et al.
Bone Marrow Transplantation
|
March 16, 2024
Treosulfan compared to busulfan in allogeneic haematopoietic stem cell transplantation for myelofibrosis: a registry-based study from the Chronic Malignancies Working Party of the EBMT
Marie Robin, Simona Iacobelli, Linda Koster, et al.
Bone Marrow Transplantation
|
January 10, 2024
Allogeneic haematopoietic cell transplantation for therapy-related myeloid neoplasms arising following treatment for lymphoma: a retrospective study on behalf of the Chronic Malignancies Working Party of the EBMT
Mitja Nabergoj, Diderik-Jan Eikema, Linda Koster, et al.
Blood
|
September 8, 2018
Measurable residual disease monitoring by NGS before allogeneic hematopoietic cell transplantation in AML
Felicitas Thol, Razif Gabdoulline, Alessandro Liebich, et al.
Neuron
|
June 1, 2022
Ketamine exerts its sustained antidepressant effects via cell-type-specific regulation of Kcnq2
Juan Pablo Lopez, Malte D Lücken, Elena Brivio, et al.
Blood Advances
|
May 4, 2023
The utility of biomarkers in acute GVHD prognostication
Nikolaos Spyrou, Yu Akahoshi, Francis Ayuk, et al.
Page
of 29